PDB Short entry for 1I7M HEADER LYASE 09-MAR-01 1I7M TITLE HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND TITLE 2 PYRUVOYL GROUP AND COMPLEXED WITH 4-AMIDINOINDAN-1-ONE-2'- TITLE 3 AMIDINOHYDRAZONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN; COMPND 3 CHAIN: B, D; COMPND 4 EC: 4.1.1.50; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN; COMPND 8 CHAIN: A, C; COMPND 9 EC: 4.1.1.50; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SPERMIDINE BIOSYNTHESIS, LYASE, DECARBOXYLASE, PYRUVATE, S- KEYWDS 2 ADENOSYLMETHIONINE, SANDWICH, ALLOSTERIC ENZYME, PYRUVOYL EXPDTA X-RAY DIFFRACTION AUTHOR W.D.TOLBERT,J.L.EKSTROM,I.I.MATHEWS,J.A.SECRIST III,A.E.PEGG, AUTHOR 2 S.E.EALICK REVDAT 8 15-NOV-23 1I7M 1 REMARK SEQADV LINK ATOM REVDAT 7 31-JAN-18 1I7M 1 JRNL REVDAT 6 24-JAN-18 1I7M 1 JRNL REVDAT 5 13-JUL-11 1I7M 1 VERSN REVDAT 4 29-SEP-10 1I7M 1 REMARK REVDAT 3 24-FEB-09 1I7M 1 VERSN REVDAT 2 01-APR-03 1I7M 1 JRNL REVDAT 1 22-AUG-01 1I7M 0 JRNL AUTH W.D.TOLBERT,J.L.EKSTROM,I.I.MATHEWS,J.A.SECRIST III, JRNL AUTH 2 P.KAPOOR,A.E.PEGG,S.E.EALICK JRNL TITL THE STRUCTURAL BASIS FOR SUBSTRATE SPECIFICITY AND JRNL TITL 2 INHIBITION OF HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE. JRNL REF BIOCHEMISTRY V. 40 9484 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11583147 JRNL DOI 10.1021/BI010735W REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.L.EKSTROM,I.I.MATHEWS,B.A.STANLEY,A.E.PEGG,S.E.EALICK REMARK 1 TITL THE CRYSTAL STRUCTURE OF HUMAN S-ADENOSYLMETHIONINE REMARK 1 TITL 2 DECARBOXYLASE AT 2.25 A RESOLUTION REVEALS A NOVEL FOLD REMARK 1 REF STRUCTURE V. 7 583 1999 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(99)80074-4 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 51995.740 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 34785 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.242 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 3542 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.24 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5269 REMARK 3 BIN R VALUE (WORKING SET) : 0.2900 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 549 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4936 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 243 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.92000 REMARK 3 B22 (A**2) : -5.95000 REMARK 3 B33 (A**2) : 12.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.14000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.019 REMARK 3 BOND ANGLES (DEGREES) : 2.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.580 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.270 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.29 REMARK 3 BSOL : 14.96 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEINMAO.PARAM REMARK 3 PARAMETER FILE 2 : ALL3.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEINMAO.TOP REMARK 3 TOPOLOGY FILE 2 : ALL3.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I7M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-01. REMARK 100 THE DEPOSITION ID IS D_1000013005. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0402 REMARK 200 MONOCHROMATOR : SI 1 1 1 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34984 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 30.715 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.19600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, TRIS-HCL PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.83600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE NATIVE ENZYME IS A DIMER AND THE DIMER IS IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE B 1 REMARK 465 GLU B 2 REMARK 465 ALA B 3 REMARK 465 GLN B 21 REMARK 465 GLN B 22 REMARK 465 PRO B 23 REMARK 465 ASP B 24 REMARK 465 ALA B 25 REMARK 465 ASN B 26 REMARK 465 GLN B 27 REMARK 465 PRO A 165 REMARK 465 GLU A 166 REMARK 465 SER A 167 REMARK 465 ARG A 168 REMARK 465 VAL A 169 REMARK 465 ILE A 170 REMARK 465 SER A 171 REMARK 465 ARG A 293 REMARK 465 THR A 294 REMARK 465 VAL A 295 REMARK 465 LEU A 296 REMARK 465 ALA A 297 REMARK 465 SER A 298 REMARK 465 GLN A 330 REMARK 465 GLN A 331 REMARK 465 GLN A 332 REMARK 465 GLN A 333 REMARK 465 SER A 334 REMARK 465 MSE D 1001 REMARK 465 GLU D 1002 REMARK 465 ALA D 1003 REMARK 465 ALA D 1004 REMARK 465 ARG D 1020 REMARK 465 GLN D 1021 REMARK 465 GLN D 1022 REMARK 465 PRO D 1023 REMARK 465 ASP D 1024 REMARK 465 ALA D 1025 REMARK 465 ASN D 1026 REMARK 465 GLN D 1027 REMARK 465 PRO C 1165 REMARK 465 GLU C 1166 REMARK 465 SER C 1167 REMARK 465 ARG C 1168 REMARK 465 VAL C 1169 REMARK 465 ILE C 1170 REMARK 465 SER C 1171 REMARK 465 ARG C 1293 REMARK 465 THR C 1294 REMARK 465 VAL C 1295 REMARK 465 LEU C 1296 REMARK 465 ALA C 1297 REMARK 465 SER C 1298 REMARK 465 GLN C 1330 REMARK 465 GLN C 1331 REMARK 465 GLN C 1332 REMARK 465 GLN C 1333 REMARK 465 SER C 1334 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER D 1066 N GLU D 1067 1.40 REMARK 500 O VAL B 47 N GLN B 48 1.61 REMARK 500 O LYS B 45 NE2 GLN B 48 2.11 REMARK 500 O GLU D 1067 O HOH D 1591 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL B 47 C GLN B 48 N -0.460 REMARK 500 GLN B 48 C CYS B 49 N -0.333 REMARK 500 CYS B 49 N CYS B 49 CA 0.279 REMARK 500 CYS B 49 C SER B 50 N -0.195 REMARK 500 SER D1066 C SER D1066 O -0.558 REMARK 500 GLU D1067 N GLU D1067 CA 0.516 REMARK 500 GLU D1067 CA GLU D1067 CB -0.251 REMARK 500 GLU D1067 CD GLU D1067 OE1 0.084 REMARK 500 GLU D1067 CD GLU D1067 OE2 -0.077 REMARK 500 GLU D1067 CA GLU D1067 C 0.187 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL B 47 CA - C - N ANGL. DEV. = 23.5 DEGREES REMARK 500 VAL B 47 O - C - N ANGL. DEV. = -25.0 DEGREES REMARK 500 GLN B 48 C - N - CA ANGL. DEV. = 39.3 DEGREES REMARK 500 GLN B 48 CA - C - O ANGL. DEV. = -40.6 DEGREES REMARK 500 GLN B 48 O - C - N ANGL. DEV. = 12.6 DEGREES REMARK 500 CYS B 49 C - N - CA ANGL. DEV. = 24.2 DEGREES REMARK 500 SER D1066 CA - C - O ANGL. DEV. = -24.3 DEGREES REMARK 500 GLU D1067 CB - CA - C ANGL. DEV. = 49.1 DEGREES REMARK 500 GLU D1067 CA - CB - CG ANGL. DEV. = 26.1 DEGREES REMARK 500 GLU D1067 N - CA - C ANGL. DEV. = -25.2 DEGREES REMARK 500 GLN C1329 C - N - CA ANGL. DEV. = 29.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 13 115.31 33.06 REMARK 500 SER B 29 -74.60 82.24 REMARK 500 GLN B 48 74.80 -7.08 REMARK 500 CYS B 49 142.88 178.79 REMARK 500 SER B 53 142.06 -174.97 REMARK 500 SER A 73 -163.63 -106.32 REMARK 500 SER A 154 -160.63 -170.68 REMARK 500 PHE A 192 30.50 -94.50 REMARK 500 PHE A 250 50.14 -146.21 REMARK 500 LYS A 276 71.89 47.30 REMARK 500 GLN A 288 -87.31 -49.28 REMARK 500 SER A 289 25.79 -71.76 REMARK 500 LYS A 291 14.18 -65.62 REMARK 500 GLN A 300 -94.13 74.31 REMARK 500 CYS A 310 100.42 -160.85 REMARK 500 PHE A 315 -166.17 -118.60 REMARK 500 ASP A 317 -37.28 -141.70 REMARK 500 LYS A 328 -78.11 -66.04 REMARK 500 SER D1029 -61.16 -168.22 REMARK 500 SER D1050 -179.94 -170.33 REMARK 500 CYS C1082 -167.90 -128.31 REMARK 500 LEU C1086 94.71 -67.97 REMARK 500 PHE C1104 108.68 -46.83 REMARK 500 PRO C1126 40.49 -92.15 REMARK 500 ALA C1145 107.95 -173.18 REMARK 500 SER C1154 -164.81 173.92 REMARK 500 ASP C1155 99.97 -64.95 REMARK 500 LEU C1162 -123.99 -108.05 REMARK 500 ASP C1163 -121.08 -116.86 REMARK 500 PHE C1192 40.05 -98.77 REMARK 500 PHE C1250 44.56 -152.26 REMARK 500 GLN C1300 -42.92 60.97 REMARK 500 ASP C1317 -52.33 -122.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL B 47 GLN B 48 -131.46 REMARK 500 GLN B 48 CYS B 49 -117.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLN B 48 -29.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PUT B 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PUT D 1350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CG A 375 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CG D 1375 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JEN RELATED DB: PDB REMARK 900 RELATED ID: 1I72 RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, 5'-DEOXY-5'-[N-METHYL-N-(2- REMARK 900 AMINOOXYETHYL) AMINO]ADENOSINE BOUND TO PVL REMARK 900 RELATED ID: 1I79 RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, 5'-DEOXY-5'-[(3-HYDRAZINOPROPYL) REMARK 900 METHYLAMINO]ADENOSINE BOUND TO PVL REMARK 900 RELATED ID: 1I7B RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, S-ADENOSYLMETHIONINE METHYL REMARK 900 ESTER BOUND TO PVL REMARK 900 RELATED ID: 1I7C RELATED DB: PDB REMARK 900 S-ADENOSYLMETHIONINE DECARBOXYLASE, METHYLGLYOXAL BIS- REMARK 900 (GUANYLHYDRAZONE) DBREF 1I7M B 1 67 UNP P17707 DCAM_HUMAN 1 67 DBREF 1I7M D 1001 1067 UNP P17707 DCAM_HUMAN 1 67 DBREF 1I7M A 68 334 UNP P17707 DCAM_HUMAN 68 334 DBREF 1I7M C 1068 1334 UNP P17707 DCAM_HUMAN 68 334 SEQADV 1I7M MSE B 1 UNP P17707 MET 1 MODIFIED RESIDUE SEQADV 1I7M MSE D 1001 UNP P17707 MET 1 MODIFIED RESIDUE SEQADV 1I7M PYR A 68 UNP P17707 SER 68 SEE REMARK 999 SEQADV 1I7M MSE A 70 UNP P17707 MET 70 MODIFIED RESIDUE SEQADV 1I7M MSE A 118 UNP P17707 MET 118 MODIFIED RESIDUE SEQADV 1I7M MSE A 149 UNP P17707 MET 149 MODIFIED RESIDUE SEQADV 1I7M MSE A 152 UNP P17707 MET 152 MODIFIED RESIDUE SEQADV 1I7M MSE A 181 UNP P17707 MET 181 MODIFIED RESIDUE SEQADV 1I7M MSE A 189 UNP P17707 MET 189 MODIFIED RESIDUE SEQADV 1I7M MSE A 194 UNP P17707 MET 194 MODIFIED RESIDUE SEQADV 1I7M MSE A 222 UNP P17707 MET 222 MODIFIED RESIDUE SEQADV 1I7M MSE A 230 UNP P17707 MET 230 MODIFIED RESIDUE SEQADV 1I7M MSE A 233 UNP P17707 MET 233 MODIFIED RESIDUE SEQADV 1I7M MSE A 314 UNP P17707 MET 314 MODIFIED RESIDUE SEQADV 1I7M PYR C 1068 UNP P17707 SER 68 SEE REMARK 999 SEQADV 1I7M MSE C 1070 UNP P17707 MET 70 MODIFIED RESIDUE SEQADV 1I7M MSE C 1118 UNP P17707 MET 118 MODIFIED RESIDUE SEQADV 1I7M MSE C 1149 UNP P17707 MET 149 MODIFIED RESIDUE SEQADV 1I7M MSE C 1152 UNP P17707 MET 152 MODIFIED RESIDUE SEQADV 1I7M MSE C 1181 UNP P17707 MET 181 MODIFIED RESIDUE SEQADV 1I7M MSE C 1189 UNP P17707 MET 189 MODIFIED RESIDUE SEQADV 1I7M MSE C 1194 UNP P17707 MET 194 MODIFIED RESIDUE SEQADV 1I7M MSE C 1222 UNP P17707 MET 222 MODIFIED RESIDUE SEQADV 1I7M MSE C 1230 UNP P17707 MET 230 MODIFIED RESIDUE SEQADV 1I7M MSE C 1233 UNP P17707 MET 233 MODIFIED RESIDUE SEQADV 1I7M MSE C 1314 UNP P17707 MET 314 MODIFIED RESIDUE SEQRES 1 B 67 MSE GLU ALA ALA HIS PHE PHE GLU GLY THR GLU LYS LEU SEQRES 2 B 67 LEU GLU VAL TRP PHE SER ARG GLN GLN PRO ASP ALA ASN SEQRES 3 B 67 GLN GLY SER GLY ASP LEU ARG THR ILE PRO ARG SER GLU SEQRES 4 B 67 TRP ASP ILE LEU LEU LYS ASP VAL GLN CYS SER ILE ILE SEQRES 5 B 67 SER VAL THR LYS THR ASP LYS GLN GLU ALA TYR VAL LEU SEQRES 6 B 67 SER GLU SEQRES 1 A 267 PYR SER MSE PHE VAL SER LYS ARG ARG PHE ILE LEU LYS SEQRES 2 A 267 THR CYS GLY THR THR LEU LEU LEU LYS ALA LEU VAL PRO SEQRES 3 A 267 LEU LEU LYS LEU ALA ARG ASP TYR SER GLY PHE ASP SER SEQRES 4 A 267 ILE GLN SER PHE PHE TYR SER ARG LYS ASN PHE MSE LYS SEQRES 5 A 267 PRO SER HIS GLN GLY TYR PRO HIS ARG ASN PHE GLN GLU SEQRES 6 A 267 GLU ILE GLU PHE LEU ASN ALA ILE PHE PRO ASN GLY ALA SEQRES 7 A 267 GLY TYR CYS MSE GLY ARG MSE ASN SER ASP CYS TRP TYR SEQRES 8 A 267 LEU TYR THR LEU ASP PHE PRO GLU SER ARG VAL ILE SER SEQRES 9 A 267 GLN PRO ASP GLN THR LEU GLU ILE LEU MSE SER GLU LEU SEQRES 10 A 267 ASP PRO ALA VAL MSE ASP GLN PHE TYR MSE LYS ASP GLY SEQRES 11 A 267 VAL THR ALA LYS ASP VAL THR ARG GLU SER GLY ILE ARG SEQRES 12 A 267 ASP LEU ILE PRO GLY SER VAL ILE ASP ALA THR MSE PHE SEQRES 13 A 267 ASN PRO CYS GLY TYR SER MSE ASN GLY MSE LYS SER ASP SEQRES 14 A 267 GLY THR TYR TRP THR ILE HIS ILE THR PRO GLU PRO GLU SEQRES 15 A 267 PHE SER TYR VAL SER PHE GLU THR ASN LEU SER GLN THR SEQRES 16 A 267 SER TYR ASP ASP LEU ILE ARG LYS VAL VAL GLU VAL PHE SEQRES 17 A 267 LYS PRO GLY LYS PHE VAL THR THR LEU PHE VAL ASN GLN SEQRES 18 A 267 SER SER LYS CYS ARG THR VAL LEU ALA SER PRO GLN LYS SEQRES 19 A 267 ILE GLU GLY PHE LYS ARG LEU ASP CYS GLN SER ALA MSE SEQRES 20 A 267 PHE ASN ASP TYR ASN PHE VAL PHE THR SER PHE ALA LYS SEQRES 21 A 267 LYS GLN GLN GLN GLN GLN SER SEQRES 1 D 67 MSE GLU ALA ALA HIS PHE PHE GLU GLY THR GLU LYS LEU SEQRES 2 D 67 LEU GLU VAL TRP PHE SER ARG GLN GLN PRO ASP ALA ASN SEQRES 3 D 67 GLN GLY SER GLY ASP LEU ARG THR ILE PRO ARG SER GLU SEQRES 4 D 67 TRP ASP ILE LEU LEU LYS ASP VAL GLN CYS SER ILE ILE SEQRES 5 D 67 SER VAL THR LYS THR ASP LYS GLN GLU ALA TYR VAL LEU SEQRES 6 D 67 SER GLU SEQRES 1 C 267 PYR SER MSE PHE VAL SER LYS ARG ARG PHE ILE LEU LYS SEQRES 2 C 267 THR CYS GLY THR THR LEU LEU LEU LYS ALA LEU VAL PRO SEQRES 3 C 267 LEU LEU LYS LEU ALA ARG ASP TYR SER GLY PHE ASP SER SEQRES 4 C 267 ILE GLN SER PHE PHE TYR SER ARG LYS ASN PHE MSE LYS SEQRES 5 C 267 PRO SER HIS GLN GLY TYR PRO HIS ARG ASN PHE GLN GLU SEQRES 6 C 267 GLU ILE GLU PHE LEU ASN ALA ILE PHE PRO ASN GLY ALA SEQRES 7 C 267 GLY TYR CYS MSE GLY ARG MSE ASN SER ASP CYS TRP TYR SEQRES 8 C 267 LEU TYR THR LEU ASP PHE PRO GLU SER ARG VAL ILE SER SEQRES 9 C 267 GLN PRO ASP GLN THR LEU GLU ILE LEU MSE SER GLU LEU SEQRES 10 C 267 ASP PRO ALA VAL MSE ASP GLN PHE TYR MSE LYS ASP GLY SEQRES 11 C 267 VAL THR ALA LYS ASP VAL THR ARG GLU SER GLY ILE ARG SEQRES 12 C 267 ASP LEU ILE PRO GLY SER VAL ILE ASP ALA THR MSE PHE SEQRES 13 C 267 ASN PRO CYS GLY TYR SER MSE ASN GLY MSE LYS SER ASP SEQRES 14 C 267 GLY THR TYR TRP THR ILE HIS ILE THR PRO GLU PRO GLU SEQRES 15 C 267 PHE SER TYR VAL SER PHE GLU THR ASN LEU SER GLN THR SEQRES 16 C 267 SER TYR ASP ASP LEU ILE ARG LYS VAL VAL GLU VAL PHE SEQRES 17 C 267 LYS PRO GLY LYS PHE VAL THR THR LEU PHE VAL ASN GLN SEQRES 18 C 267 SER SER LYS CYS ARG THR VAL LEU ALA SER PRO GLN LYS SEQRES 19 C 267 ILE GLU GLY PHE LYS ARG LEU ASP CYS GLN SER ALA MSE SEQRES 20 C 267 PHE ASN ASP TYR ASN PHE VAL PHE THR SER PHE ALA LYS SEQRES 21 C 267 LYS GLN GLN GLN GLN GLN SER MODRES 1I7M MSE A 70 MET SELENOMETHIONINE MODRES 1I7M MSE A 118 MET SELENOMETHIONINE MODRES 1I7M MSE A 149 MET SELENOMETHIONINE MODRES 1I7M MSE A 152 MET SELENOMETHIONINE MODRES 1I7M MSE A 181 MET SELENOMETHIONINE MODRES 1I7M MSE A 189 MET SELENOMETHIONINE MODRES 1I7M MSE A 194 MET SELENOMETHIONINE MODRES 1I7M MSE A 222 MET SELENOMETHIONINE MODRES 1I7M MSE A 230 MET SELENOMETHIONINE MODRES 1I7M MSE A 233 MET SELENOMETHIONINE MODRES 1I7M MSE A 314 MET SELENOMETHIONINE MODRES 1I7M MSE C 1070 MET SELENOMETHIONINE MODRES 1I7M MSE C 1118 MET SELENOMETHIONINE MODRES 1I7M MSE C 1149 MET SELENOMETHIONINE MODRES 1I7M MSE C 1152 MET SELENOMETHIONINE MODRES 1I7M MSE C 1181 MET SELENOMETHIONINE MODRES 1I7M MSE C 1189 MET SELENOMETHIONINE MODRES 1I7M MSE C 1194 MET SELENOMETHIONINE MODRES 1I7M MSE C 1222 MET SELENOMETHIONINE MODRES 1I7M MSE C 1230 MET SELENOMETHIONINE MODRES 1I7M MSE C 1233 MET SELENOMETHIONINE MODRES 1I7M MSE C 1314 MET SELENOMETHIONINE HET PYR A 68 5 HET MSE A 70 8 HET MSE A 118 8 HET MSE A 149 8 HET MSE A 152 8 HET MSE A 181 8 HET MSE A 189 8 HET MSE A 194 8 HET MSE A 222 8 HET MSE A 230 8 HET MSE A 233 8 HET MSE A 314 8 HET PYR C1068 5 HET MSE C1070 8 HET MSE C1118 8 HET MSE C1149 8 HET MSE C1152 8 HET MSE C1181 8 HET MSE C1189 8 HET MSE C1194 8 HET MSE C1222 8 HET MSE C1230 8 HET MSE C1233 8 HET MSE C1314 8 HET PUT B 350 6 HET CG A 375 17 HET PUT D1350 6 HET CG D1375 17 HETNAM PYR PYRUVIC ACID HETNAM MSE SELENOMETHIONINE HETNAM PUT 1,4-DIAMINOBUTANE HETNAM CG 4-AMIDINOINDAN-1-ONE-2'-AMIDINOHYDRAZONE HETSYN PUT PUTRESCINE FORMUL 2 PYR 2(C3 H4 O3) FORMUL 2 MSE 22(C5 H11 N O2 SE) FORMUL 5 PUT 2(C4 H12 N2) FORMUL 6 CG 2(C11 H14 N6) FORMUL 9 HOH *243(H2 O) HELIX 1 1 ASP B 31 ILE B 35 5 5 HELIX 2 2 PRO B 36 ASP B 46 1 11 HELIX 3 3 LEU A 86 LYS A 89 5 4 HELIX 4 4 ALA A 90 TYR A 101 1 12 HELIX 5 5 LYS A 119 GLN A 123 5 5 HELIX 6 6 ASN A 129 ALA A 139 1 11 HELIX 7 7 ASP A 185 ASP A 190 1 6 HELIX 8 8 THR A 199 GLY A 208 1 10 HELIX 9 9 GLY A 208 ILE A 213 1 6 HELIX 10 10 TYR A 264 LYS A 276 1 13 HELIX 11 11 ASP D 1031 ILE D 1035 5 5 HELIX 12 12 PRO D 1036 ASP D 1046 1 11 HELIX 13 13 LEU C 1087 LYS C 1089 5 3 HELIX 14 14 ALA C 1090 TYR C 1101 1 12 HELIX 15 15 LYS C 1119 GLN C 1123 5 5 HELIX 16 16 ASN C 1129 ALA C 1139 1 11 HELIX 17 17 ASP C 1185 ASP C 1190 1 6 HELIX 18 18 THR C 1199 SER C 1207 1 9 HELIX 19 19 ILE C 1209 ILE C 1213 5 5 HELIX 20 20 TYR C 1264 LYS C 1276 1 13 SHEET 1 A 8 ILE B 51 LYS B 56 0 SHEET 2 A 8 GLU B 61 LEU B 65 -1 N ALA B 62 O THR B 55 SHEET 3 A 8 MSE A 70 VAL A 72 -1 N MSE A 70 O TYR B 63 SHEET 4 A 8 ARG A 76 LEU A 79 -1 N ILE A 78 O PHE A 71 SHEET 5 A 8 LEU B 14 SER B 19 -1 N LEU B 14 O LEU A 79 SHEET 6 A 8 SER A 106 LYS A 115 -1 O SER A 106 N SER B 19 SHEET 7 A 8 CYS A 156 LEU A 162 -1 N TYR A 158 O ARG A 114 SHEET 8 A 8 GLY A 144 GLY A 150 -1 N ALA A 145 O THR A 161 SHEET 1 B16 VAL A 217 MSE A 222 0 SHEET 2 B16 TYR A 228 MSE A 233 -1 N SER A 229 O THR A 221 SHEET 3 B16 TYR A 239 THR A 245 -1 O TRP A 240 N GLY A 232 SHEET 4 B16 TYR A 252 THR A 257 -1 N TYR A 252 O THR A 245 SHEET 5 B16 GLN A 175 SER A 182 -1 N LEU A 177 O THR A 257 SHEET 6 B16 LYS A 279 VAL A 286 -1 O LYS A 279 N SER A 182 SHEET 7 B16 ASN A 319 LYS A 327 -1 N ASN A 319 O VAL A 286 SHEET 8 B16 PHE A 305 MSE A 314 -1 N LYS A 306 O ALA A 326 SHEET 9 B16 PHE C1305 MSE C1314 -1 O CYS C1310 N MSE A 314 SHEET 10 B16 ASN C1319 LYS C1327 -1 N PHE C1320 O ALA C1313 SHEET 11 B16 LYS C1279 VAL C1286 -1 O PHE C1280 N PHE C1325 SHEET 12 B16 GLN C1175 SER C1182 -1 O THR C1176 N PHE C1285 SHEET 13 B16 TYR C1252 THR C1257 -1 O VAL C1253 N MSE C1181 SHEET 14 B16 TYR C1239 THR C1245 -1 O THR C1241 N GLU C1256 SHEET 15 B16 TYR C1228 MSE C1233 -1 O TYR C1228 N ILE C1244 SHEET 16 B16 VAL C1217 MSE C1222 -1 N VAL C1217 O MSE C1233 SHEET 1 C 8 ILE D1051 LYS D1056 0 SHEET 2 C 8 GLN D1060 LEU D1065 -1 N ALA D1062 O THR D1055 SHEET 3 C 8 MSE C1070 SER C1073 -1 O MSE C1070 N TYR D1063 SHEET 4 C 8 ARG C1076 THR C1081 -1 O ARG C1076 N SER C1073 SHEET 5 C 8 LYS D1012 TRP D1017 -1 N LYS D1012 O THR C1081 SHEET 6 C 8 SER C1109 LYS C1115 -1 O SER C1109 N TRP D1017 SHEET 7 C 8 CYS C1156 THR C1161 -1 N TYR C1158 O ARG C1114 SHEET 8 C 8 GLY C1146 GLY C1150 -1 O TYR C1147 N LEU C1159 LINK C PYR A 68 N SER A 69 1555 1555 1.32 LINK C SER A 69 N MSE A 70 1555 1555 1.34 LINK C MSE A 70 N PHE A 71 1555 1555 1.33 LINK C PHE A 117 N MSE A 118 1555 1555 1.33 LINK C MSE A 118 N LYS A 119 1555 1555 1.33 LINK C CYS A 148 N MSE A 149 1555 1555 1.33 LINK C MSE A 149 N GLY A 150 1555 1555 1.33 LINK C ARG A 151 N MSE A 152 1555 1555 1.33 LINK C MSE A 152 N ASN A 153 1555 1555 1.33 LINK C LEU A 180 N MSE A 181 1555 1555 1.33 LINK C MSE A 181 N SER A 182 1555 1555 1.33 LINK C VAL A 188 N MSE A 189 1555 1555 1.33 LINK C MSE A 189 N ASP A 190 1555 1555 1.34 LINK C TYR A 193 N MSE A 194 1555 1555 1.34 LINK C MSE A 194 N LYS A 195 1555 1555 1.33 LINK C THR A 221 N MSE A 222 1555 1555 1.32 LINK C MSE A 222 N PHE A 223 1555 1555 1.33 LINK C SER A 229 N MSE A 230 1555 1555 1.32 LINK C MSE A 230 N ASN A 231 1555 1555 1.33 LINK C GLY A 232 N MSE A 233 1555 1555 1.32 LINK C MSE A 233 N LYS A 234 1555 1555 1.33 LINK C ALA A 313 N MSE A 314 1555 1555 1.33 LINK C MSE A 314 N PHE A 315 1555 1555 1.32 LINK C PYR C1068 N SER C1069 1555 1555 1.34 LINK C SER C1069 N MSE C1070 1555 1555 1.33 LINK C MSE C1070 N PHE C1071 1555 1555 1.33 LINK C PHE C1117 N MSE C1118 1555 1555 1.33 LINK C MSE C1118 N LYS C1119 1555 1555 1.33 LINK C CYS C1148 N MSE C1149 1555 1555 1.33 LINK C MSE C1149 N GLY C1150 1555 1555 1.33 LINK C ARG C1151 N MSE C1152 1555 1555 1.33 LINK C MSE C1152 N ASN C1153 1555 1555 1.33 LINK C LEU C1180 N MSE C1181 1555 1555 1.33 LINK C MSE C1181 N SER C1182 1555 1555 1.33 LINK C VAL C1188 N MSE C1189 1555 1555 1.33 LINK C MSE C1189 N ASP C1190 1555 1555 1.34 LINK C TYR C1193 N MSE C1194 1555 1555 1.33 LINK C MSE C1194 N LYS C1195 1555 1555 1.33 LINK C THR C1221 N MSE C1222 1555 1555 1.35 LINK C MSE C1222 N PHE C1223 1555 1555 1.33 LINK C SER C1229 N MSE C1230 1555 1555 1.33 LINK C MSE C1230 N ASN C1231 1555 1555 1.33 LINK C GLY C1232 N MSE C1233 1555 1555 1.33 LINK C MSE C1233 N LYS C1234 1555 1555 1.33 LINK C ALA C1313 N MSE C1314 1555 1555 1.32 LINK C MSE C1314 N PHE C1315 1555 1555 1.33 CISPEP 1 TYR A 125 PRO A 126 0 0.07 CISPEP 2 ASN A 224 PRO A 225 0 0.24 CISPEP 3 TYR C 1125 PRO C 1126 0 -0.05 CISPEP 4 ASN C 1224 PRO C 1225 0 -0.05 SITE 1 AC1 9 PHE A 111 ASP A 174 THR A 176 TYR A 318 SITE 2 AC1 9 HOH A1403 LEU B 13 GLU B 15 HOH B1438 SITE 3 AC1 9 HOH B1445 SITE 1 AC2 10 PHE C1111 ASP C1174 THR C1176 PHE C1285 SITE 2 AC2 10 TYR C1318 HOH C1401 LEU D1013 GLU D1015 SITE 3 AC2 10 HOH D1419 HOH D1447 SITE 1 AC3 11 PYR A 68 PHE A 223 CYS A 226 SER A 229 SITE 2 AC3 11 HIS A 243 ILE A 244 GLU A 247 PHE B 7 SITE 3 AC3 11 LEU B 65 SER B 66 GLU B 67 SITE 1 AC4 11 PYR C1068 PHE C1223 CYS C1226 SER C1229 SITE 2 AC4 11 HIS C1243 ILE C1244 THR C1245 GLU C1247 SITE 3 AC4 11 LEU D1065 SER D1066 GLU D1067 CRYST1 73.899 55.672 96.086 90.00 110.39 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013532 0.000000 0.005029 0.00000 SCALE2 0.000000 0.017962 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011103 0.00000